Single gene therapy injection may correct devastating neurological disordersNovember 14th, 2007 - 1:52 am ICT by admin
“This may represent a new strategy for treating genetic diseases of the central nervous system,” added Dr. Wolfe, who is also the leader in the study published in the Journal of Neuroscience.
The mice used in the study were specially bred to have the neurogenetic disease mucopolysaccharidosis type VII (MPS VII), a rare multi-system disease that causes mental retardation and death in childhood or early adulthood, which is also known as Sly syndrome.
Dr. Wolfe revealed that he targeted a particular region of the mouse brain called the ventral tegmental area (VTA), which has numerous connections with the rest of the brain. He used a neutralized virus called adeno-associated virus (AAV) as a vector, the delivery vehicle for the gene that carries coded instructions to produce the desired enzyme.
“We found that one subtype of AAV was particularly effective for transporting the gene. The neural pathways carried the virus throughout the brain, where the gene produced the enzyme. The enzyme then cleaned up the storage lesions to the point that these storage lesions were indistinguishable from those found in the brains of normal mice,” said Wolfe.
He further said that one of the advantages of lysosomal enzymes was that cells receiving the delivered gene secrete beneficial enzymes to neighbouring cells, creating a “sphere of correction”.
Dr. Wolfe said that the level of correction resulting from a single injection was “unprecedented”.
According to him, two millilitres of injected gene therapy might treat a one-year-old child if the animal results could be successfully extrapolated to humans.
He, however, has admitted that it may take several years before direct human treatments may be available.
He also revealed that he was planning further studies to determine whether his technique would be effective in animals larger than mice. (ANI)
- Promising results of gene therapy to treat eye diseases - Aug 14, 2010
- 'Novel treatment for advanced Parkinson's disease' found - Mar 17, 2011
- Gene therapy to brain may treat major depression - Oct 21, 2010
- New method to turn blood-brain barrier into therapy delivery system - Sep 22, 2009
- Liver, not brain, may be source of Alzheimer's plaques - Mar 04, 2011
- Blood cells successfully reprogrammed - Nov 10, 2009
- Diarrhea-causing bacteria turned into antiviral gene therapy agent - Feb 08, 2011
- New study explains how brain knows what the nose smells - Feb 05, 2011
- Scientists alter genetic code to cure hereditary disease - Jun 27, 2011
- Sleep disorders are early signs of Alzheimer's - Sep 06, 2012
- Genes determine a lot more than just our looks - Nov 08, 2010
- Magnetic pulses could overcome depression, schizophrenia - Feb 08, 2012
- Uncontrolled brain activity linked to epilepsy - Apr 26, 2010
- Potential new multiple sclerosis treatment - Nov 19, 2010
- Gene therapy restores olfactory sense in mice - Sep 03, 2012
Tags: aav, beneficial, brain, central nervous system, diseases of the central nervous system, early adulthood, extrapolated, gene therapy, genetic diseases, journal of neuroscience, lesions, lysosomal enzymes, mice, mucopolysaccharidosis type, neighbouring cells, neural pathways, neurological disorders, said wolfe, virus, vta